Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A2J35 | — |
administered only the sterile water for injection component of the Priorix vaccine; administered only the sterile water for injection component of the Priorix vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 61-year-old female patient who received MMR (Priorix) (batch number A2J35, expiry date 01-SEP-2025) for prophylaxis. On 02-MAR-2025, the patient received Priorix. On 02-MAR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: administered only the sterile water for injection component of the Priorix vaccine) and inappropriate dose of vaccine administered (Verbatim: administered only the sterile water for injection component of the Priorix vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 03-MAR-2025 Pharmacy manager reported that two patients were administered only the sterile water for injection component of the Priorix vaccine which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This case is linked with US2025026207, reported by same reporter different patient.; Sender's Comments: US-GSK-US2025026207:Same reporter/Diffrent patient